Biomedical Engineering Reference
In-Depth Information
56. Vernon MO, Hayden MK, Trick WE et al (2006) Chlorhexidine gluconate to cleanse patients
in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of
vancomycin-resistant enterococci. Arch Intern Med 166:306-312
57. Mayer RA, Geha RC, Helfand MS, Hoyen CK, Salata RA, Donskey CJ (2003) Role of fecal
incontinence in contamination of the environment with vancomycin-resistant enterococci.
Am J Infect Control 31:221-225
58. Al-Nassir WN, Sethi AK, Nerandzic MM, Bobulsky GS, Jump RL, Donskey CJ (2008)
Comparison of clinical and microbiological response to treatment of Clostridium difficile-
associated disease with metronidazole and vancomycin. Clin Infect Dis 47:56-62
59. Atmar RL, Opekun AR, Gilger MA et al (2008) Norwalk virus shedding after experimental
human infection. Emerg Infect Dis 14:1553-1557
60. Caul EO (1994) Small round structured viruses: airborne transmission and hospital control.
Lancet 343:1240-1242
61. Boyce JM, Havill NL, Otter JA et al (2008) Impact of hydrogen peroxide vapor room
decontamination on Clostridium difficile environmental contamination and transmission in
a healthcare setting. Infect Control Hosp Epidemiol 29:723-729
62. Rutala WA, Katz EB, Sherertz RJ, Sarubbi FA Jr (1983) Environmental study of a
methicillin-resistant Staphylococcus aureus epidemic in a burn unit. J Clin Microbiol
18:683-688
63. Schmidt MG, Attaway HH, Sharpe PA et al (2012) Sustained reduction of microbial burden
on common hospital surfaces through introduction of copper. J Clin Microbiol 50:2217-2223
64. Cooper RA, Griffith CJ, Malik RE, Obee P, Looker N (2007) Monitoring the effectiveness of
cleaning in four British hospitals. Am J Infect Control 35:338-341
65. Foster WD, Hutt MS (1960) Experimental staphylococcal
infections in man. Lancet
2:1373-1376
66. Lawley TD, Clare S, Deakin LJ et al (2010) Use of purified Clostridium difficile spores
to facilitate evaluation of health care disinfection regimens. Appl Environ Microbiol
76:6895-6900
67. Teunis PF, Moe CL, Liu P et al (2008) Norwalk virus: how infectious is it? J Med Virol
80:1468-1476
68. Dancer SJ (2004) How do we assess hospital cleaning? A proposal for microbiological
standards for surface hygiene in hospitals. J Hosp Infect 56:10-15
69. Wagenvoort JH, Joosten EJ (2002) An outbreak Acinetobacter baumannii that mimics MRSA
in its environmental longevity. J Hosp Infect 52:226-227
70. Wagenvoort JH, De Brauwer EI, Penders RJ, Willems RJ, Top J, Bonten MJ (2011)
Environmental survival of vancomycin-resistant Enterococcus faecium. J Hosp Infect
77:282-283
71. Wagenvoort JH, Sluijsmans W, Penders RJ (2000) Better environmental survival of outbreak
vs. sporadic MRSA isolates. J Hosp Infect 45:231-234
72. Doultree JC, Druce JD, Birch CJ, Bowden DS, Marshall JA (1999) Inactivation of feline
calicivirus, a Norwalk virus surrogate. J Hosp Infect 41:51-57
73. Kramer A, Schwebke I, Kampf G (2006) How long do nosocomial pathogens persist on
inanimate surfaces? A systematic review. BMC Infect Dis 6:130
74. McDonnell G, Russell AD (1999) Antiseptics and disinfectants: activity, action, and
resistance. Clin Microbiol Rev 12:147-179
75. Barker J, Vipond IB, Bloomfield SF (2004) Effects of cleaning and disinfection in reducing
the spread of Norovirus contamination via environmental surfaces. J Hosp Infect 58:42-49
76. Ali S, Moore G, Wilson AP (2011) Spread and persistence of Clostridium difficile spores
during and after cleaning with sporicidal disinfectants. J Hosp Infect 79:97-98
77. Dettenkofer M, Block C (2005) Hospital disinfection: efficacy and safety issues. Curr Opin
Infect Dis 18:320-325
Search WWH ::




Custom Search